Largest biotech by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Moderna has the lowest figure of the 24 biotech ranked by earnings, at -CHF 2.4B, followed by BioNTech (-CHF 1.1B) and Revolution Medicines (-CHF 954.3M). Figures as of 18 Nov 2026, 16:31 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- Lowest
- Moderna-CHF 2.4B
- Median
- -CHF 57.9M
- Combined market value
- CHF 709.3B
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Earnings ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ModernaMRNA · Health Care | -CHF 2.4B | CHF 68.8B | CHF 170.00 | 2.55% down | 755% up | ||
| 2 | BioNTechBNTX · Health Care | -CHF 1.1B | CHF 17.6B | CHF 70.94 | 0.89% down | 16% down | ||
| 3 | Revolution MedicinesRVMD · Health Care | -CHF 954.3M | CHF 29.3B | CHF 135.54 | 1.23% down | 131% up | ||
| 4 | VaxcytePCVX · Health Care | -CHF 646.7M | CHF 7.9B | CHF 49.76 | 0.69% down | 22% up | ||
| 5 | CRISPR TherapeuticsCRSP · Health Care | -CHF 490.6M | CHF 3.4B | CHF 35.28 | 4.16% up | 21% down | ||
| 6 | ImmunovantIMVT · Health Care | -CHF 426.5M | CHF 5.9B | CHF 28.32 | 1.08% up | 43% up | ||
| 7 | Scholar Rock HoldingSRRK · Health Care | -CHF 318.8M | CHF 4.8B | CHF 39.73 | 4.48% up | 14% up | ||
| 8 | ImmunityBioIBRX · Health Care | -CHF 296.4M | CHF 5.9B | CHF 5.58 | 5.59% up | 193% up | ||
| 9 | Kymera TherapeuticsKYMR · Health Care | -CHF 262.6M | CHF 8.7B | CHF 102.06 | 0.44% down | 87% up | ||
| 10 | Kodiak SciencesKOD · Health Care | -CHF 194M | CHF 5.3B | CHF 81.67 | 0.02% up | 396% up | ||
| 11 | CG OncologyCGON · Health Care | -CHF 135.8M | CHF 6B | CHF 67.42 | 1.25% up | 85% up | ||
| 12 | Twist BioscienceTWST · Health Care | -CHF 65.5M | CHF 6.7B | CHF 97.64 | 3.35% up | 340% up | ||
| 13 | Adaptive BiotechnologiesADPT · Health Care | -CHF 50.2M | CHF 3.9B | CHF 23.84 | 0.81% down | 88% up | ||
| 14 | RepligenRGEN · Health Care | CHF 41.2M | CHF 9.2B | CHF 144.47 | 5.60% up | 5% up | ||
| 15 | Bio-TechneTECH · Health Care | CHF 153.4M | CHF 9.6B | CHF 61.35 | 0.14% up | 26% up | ||
| 16 | Krystal BiotechKRYS · Health Care | CHF 172.8M | CHF 7.8B | CHF 261.54 | 3.86% up | 46% up | ||
| 17 | Halozyme TherapeuticsHALO · Health Care | CHF 267.3M | CHF 9.3B | CHF 81.91 | 1.18% up | 37% up | ||
| 18 | QiagenQGEN · Health Care | CHF 358.4M | CHF 8.6B | CHF 41.79 | 0.41% down | 12% up | ||
| 19 | Neurocrine BiosciencesNBIX · Health Care | CHF 403.7M | CHF 13.9B | CHF 137.36 | 1.86% down | 20% up | ||
| 20 | ExelixisEXEL · Health Care | CHF 660.1M | CHF 14.2B | CHF 58.34 | 0.96% up | 63% up | ||
| 21 | argenxARGX · Health Care | CHF 1.1B | CHF 50B | CHF 795.62 | 0.45% down | 4% up | ||
| 22 | BiogenBIIB · Health Care | CHF 1.1B | CHF 31.2B | CHF 210.82 | 0.34% down | 49% up | ||
| 23 | AmgenAMGN · Health Care | CHF 6.5B | CHF 203.9B | CHF 376.99 | 2.40% down | 34% up | ||
| 24 | Gilead SciencesGILD · Health Care | CHF 7.2B | CHF 177.3B | CHF 142.93 | 0.48% down | 33% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8435 CHF).
Questions and answers
Which biotech have the lowest earnings?
Moderna (-CHF 2.4B), BioNTech (-CHF 1.1B) and Revolution Medicines (-CHF 954.3M) have the lowest earnings of the 24 biotech ranked here as of 18 Nov 2026, 16:31 UTC.
How many biotech are in this ranking?
24 are ranked by earnings.
What are these biotech worth together?
The 24 biotech ranked by earnings have a combined market value of CHF 709.3B as of 18 Nov 2026, 16:31 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest biotech by earnings”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.